Downloads
-
How Sethera Harnesses A Promiscuous Enzyme To Make Recombinant Peptides
10/21/2025
A class of enzymes previously believed to be specific and intolerant of change might actually have broad applicability.
-
Risk-Based Analytical Method Selection In Cleaning Validation Using ASTM International Standards
10/14/2025
This in-depth article describes risk in cleaning and provides a science- and risk-based framework for selecting analytical methods using ASTM International standards.
-
What You Should Know About USP's Bioassay Updates
10/2/2025
The United States Pharmacopeia is overhauling general chapters to align them with current industry standards. One scientist on the project helps us unpack the changes.
-
Automation In The Lab: Lessons From Successes And Setbacks
9/24/2025
Real-world examples show that, in some labs, manual screenings disappeared altogether, replaced by automated runs that now cover entire departments.
-
Unpacking Pfizer's Advanced Process Control Platform For Upstream Ops
8/29/2025
Pfizer's advanced process control platform gives modelers more dexterity compared to default controllers, thus speeding up process development.
-
Weight Of Evidence Assessments For Carcinogenicity Studies: An Overview
8/20/2025
Carcinogenicity assessments often rely heavily on two-year rodent bioassays. The weight of evidence (WoE) approach seeks to streamline this process, combining thorough science with regulatory practicality.
-
Report: Nearly 40% Of Biomanufacturers Eyeing Continuous Processing
8/19/2025
Continuous perfusion manufacturing came about before the technology was mature enough to support it. Now, new data suggests an inflection point in the status quo.
-
The Building Blocks Of A Robust Analytical Assay
8/1/2025
Analytical assays aren't just important for quality control. Regulators expect them. These tips will help if you're just starting to build your analytical package.
-
Environmental Monitoring Performance Qualification In New Drug Manufacturing Facilities
8/1/2025
In setting up a new manufacturing facility, a robust process for environmental monitoring must be established and cleanrooms in the classified areas must be properly qualified. Here are critical considerations to keep in mind.
-
Formulation Development Of A JAK1 Inhibitor Extended-Release Tablet
6/19/2025
This scientific article presents a summary of the formulation development strategy of a JAK1 inhibitor extended-release tablet, with a focus on experimental design, data interpretation, and formulation decision-making.